A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -25.95% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -2.50%. Over the past 30 days, the price of RAPT has fallen by 46.18%. And in the last five days, it has surged by 32.16%.
RAPT Therapeutics Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $4.21 on 06/07/24, while the lowest value for the same period was recorded at $0.71 on 05/15/25.
52-week price history of RAPT Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. RAPT Therapeutics Inc’s current trading price is -72.21% away from its 52-week high, while its distance from the 52-week low is 65.22%. The stock’s price range during this period has varied between$0.71 and $4.21. The RAPT Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.95 million for the day, a figure considerably higher than their average daily volume of 0.93 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
RAPT Therapeutics Inc (RAPT) has experienced a quarterly rise of 3.54% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 154.78M and boasts a workforce of 68 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
RAPT’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RAPT stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
